Conmed (CNMD) Non-Current Debt (2010 - 2026)

Conmed's Non-Current Debt history runs 17 years deep, the most recent figure standing at $860.2 million for Q1 2026.

• Quarterly Non-Current Debt fell 3.51% year-over-year to $860.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $860.2 million (down 3.51% YoY) and the FY2025 annual result came in at $834.2 million, down 7.83% from the prior year.
• Non-Current Debt was $860.2 million for Q1 2026 at Conmed, up from $834.2 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $1.0 billion in Q3 2022 and bottomed at $703.5 million in Q1 2022.
• A 5-year average of $924.1 million and a median of $942.2 million in 2023 frame the typical range for Non-Current Debt.
• Annual changes were most pronounced in 2022 — Non-Current Debt surged 47.36% — and 2025, when it slipped 9.97%.
• Conmed's Non-Current Debt stood at $985.1 million in 2022, then dropped by 1.21% to $973.1 million in 2023, then dropped by 7.0% to $905.1 million in 2024, then fell by 7.83% to $834.2 million in 2025, then climbed by 3.11% to $860.2 million in 2026.
• Business Quant data shows CNMD's Non-Current Debt at $860.2 million in Q1 2026, $834.2 million in Q4 2025, and $853.0 million in Q3 2025.